LINC00604

Across TCGA pan-cancer cohorts, LINC00604 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC00604 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher LINC00604 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00604 expression acts as an unfavorable survival marker, although some lineages such as KIRC and MESO show a favorable association.

TGCT, KIRP, and LUAD are the cancer types where LINC00604 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.363	0.954	<.001	90	view →
KIRP	OS	Tertile	All	0.224	0.720	<.001	63	view →
LUAD	DFS	Tertile	IV	0.190	0.758	<.001	54	view →
ACC	DFS	Tertile	All	0.202	0.737	<.001	51	view →
THCA	OS	Tertile	IV	0.579	0.986	<.001	48	view →
UCEC	OS	Tertile	II,III,IV	0.561	0.857	.002	30	view →
SKCM	DFS	Tertile	All	0.496	0.775	.005	21	view →
KIRC	DFS	Tertile	III,IV	0.729	0.404	.040	18	view →
LAML	DFS	Tertile	All	0.195	0.588	.035	18	view →
MESO	OS	Tertile	III,IV	1.000	0.383	.020	12	view →
LIHC	DFS	Tertile	III,IV	0.045	0.333	<.001	9	view →
SARC	DFS	Tertile	All	0.351	0.650	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC00604–TGCT (DFS)

Open the TGCT breakdown →